Nachrichten aus der Welt der Medizin. Zur Verfügung gestellen von CMG (Current Medicine Group).
-
- 03.09.2010
- Direct LDL-cholesterol assay may suit fasting and nonfasting serum samples Japanese research suggests that epidemiological studies can assess levels of low-density lipoprotein cholesterol using direct homogenous assay in both fasting and nonfasting serum samples.
-
- 03.09.2010
- Elevated blood glucose disrupts normal immune responses in diabetics UK researchers suggest that elevated blood glucose levels in patients with diabetes can cause competitive inhibition of immune receptors and hinder the body’s ability to fight infection.
-
- 03.09.2010
- Fenofibrate added to pravastatin could help control mixed hyperlipidemia Adding 160 mg fenofibrate daily to 40 mg pravastatin can significantly improve the lipid profile of high-risk patients whose mixed hyperlipidemia is not controlled by the statin alone, trial findings suggest.
-
- 03.09.2010
- GWTG–Stroke model applicable to other countries The Get With The Guidelines–Stroke model for quality stroke care may be useful globally, say Taiwanese researchers.
-
- 03.09.2010
- ISAR-REACT 3A: Reduced UFH dose in PCI patients lowers bleeding risk Lowering the dose of unfractionated heparin in patients undergoing percutaneous coronary intervention offers a clinical benefit driven by reductions in bleeding risk, as shown by results from the ISAR-REACT 3A study.
